Arrowhead Pharmaceuticals Inc (ARWR)
24.76
-0.46
(-1.80%)
USD |
NASDAQ |
May 09, 16:00
24.74
-0.02
(-0.10%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Cash from Investing (TTM): 49.38M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 49.38M |
| September 30, 2023 | -96.16M |
| June 30, 2023 | -90.22M |
| March 31, 2023 | -19.04M |
| December 31, 2022 | -52.73M |
| September 30, 2022 | -5.417M |
| June 30, 2022 | -160.11M |
| March 31, 2022 | -240.93M |
| December 31, 2021 | -205.22M |
| September 30, 2021 | -141.68M |
| June 30, 2021 | -89.33M |
| March 31, 2021 | -75.82M |
| December 31, 2020 | -219.90M |
| September 30, 2020 | -240.78M |
| June 30, 2020 | -158.05M |
| March 31, 2020 | -137.62M |
| December 31, 2019 | 29.29M |
| September 30, 2019 | -47.75M |
| June 30, 2019 | -61.33M |
| March 31, 2019 | -104.58M |
| December 31, 2018 | -76.55M |
| September 30, 2018 | -7.435M |
| June 30, 2018 | -14.90M |
| March 31, 2018 | 1.028M |
| December 31, 2017 | -41.99M |
| Date | Value |
|---|---|
| September 30, 2017 | -48.64M |
| June 30, 2017 | -46.14M |
| March 31, 2017 | -23.75M |
| December 31, 2016 | 5.558M |
| September 30, 2016 | 13.45M |
| June 30, 2016 | 21.01M |
| March 31, 2016 | 15.52M |
| December 31, 2015 | 21.21M |
| September 30, 2015 | 14.12M |
| June 30, 2015 | 12.82M |
| March 31, 2015 | 9.780M |
| December 31, 2014 | -25.84M |
| September 30, 2014 | -36.48M |
| June 30, 2014 | -47.55M |
| March 31, 2014 | -52.74M |
| December 31, 2013 | -24.78M |
| September 30, 2013 | -9.521M |
| June 30, 2013 | -2.822M |
| March 31, 2013 | 1.360M |
| December 31, 2012 | 0.013M |
| September 30, 2012 | 0.4406M |
| June 30, 2012 | 0.6667M |
| March 31, 2012 | 1.280M |
| December 31, 2011 | 0.3642M |
| September 30, 2011 | -0.1754M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-240.93M
Minimum
Mar 2022
49.38M
Maximum
Dec 2023
-103.34M
Average
-90.22M
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -217.60M |
| Viking Therapeutics Inc | -641.08M |
| Akero Therapeutics Inc | -223.62M |
| 89bio Inc | -123.02M |
| Sagimet Biosciences Inc | 12.58M |